GUANGZHOU, China, Oct. 10, 2025 /PRNewswire/ — POMDOCTOR LIMITED (Nasdaq: POM) (the “Company” or “POMDOCTOR”), a leading online medical services platform for chronic diseases in China, today announced the underwriter of its initial public offering […]
GUANGZHOU, China, Oct. 10, 2025 /PRNewswire/ — POMDOCTOR LIMITED (Nasdaq: POM) (the “Company” or “POMDOCTOR”), a leading online medical services platform for chronic diseases in China, today announced the underwriter of its initial public offering […]
GUANGZHOU, China, Oct. 10, 2025 /PRNewswire/ — POMDOCTOR LIMITED (Nasdaq: POM) (the “Company” or “POMDOCTOR”), a leading online medical services platform for chronic diseases in China, today announced the underwriter of its initial public offering […]
GUANGZHOU, China, Oct. 10, 2025 /PRNewswire/ — POMDOCTOR LIMITED (Nasdaq: POM) (the “Company” or “POMDOCTOR”), a leading online medical services platform for chronic diseases in China, today announced the underwriter of its initial public offering […]
GUANGZHOU, China, Oct. 9, 2025 /PRNewswire/ — POMDOCTOR LIMITED (Nasdaq: POM) (the “Company” or “POMDOCTOR”), a leading online medical services platform for chronic diseases in China, today announced the closing of its initial public offering […]
